ÂÜÀòÂÒÂ×

Miranda Carleton, Ph.D. has extensive work experience in various roles. Miranda is currently working as a Senior Business Analyst at Lifescience Dynamics Limited, where they perform high-quality research and analysis to generate impactful insights for clients. Miranda also oversees project workstreams and manages project timetables and budgets. Prior to this, they worked as a Business Analyst at the same company.

Miranda's previous experience includes being a PhD Candidate at the University of Toronto from 2016 to 2021. During this time, they worked in Dr. Michael Sefton's Lab and conducted research in the field. Miranda also served as a Teaching Assistant at the university during the same period.

In 2016, Miranda worked as a Summer Research Student at the University Health Network, where they designed and tested a culture model related to lung epithelial development. Miranda was supervised by Dr. Tom Waddell and Professor Alison McGuigan.

In 2015, Miranda was a Summer Research Student at the University of Toronto, where they investigated the effect of hyperglycemia and mechanical stimulation on osteocytes. Their research was supported by a CIHR Summer Studentship Award and they were supervised by Professor Lidan You.

Overall, Miranda Carleton, Ph.D. has diverse work experience in research and analysis, with a focus on the healthcare and life sciences industries.

Miranda Carleton, Ph.D. obtained their Bachelor of Applied Science (BASc) in Engineering Science from the University of Toronto, where they attended from 2012 to 2016. Miranda then pursued further education at the same institution and received their Doctor of Philosophy (PhD) in Biomedical Engineering from the University of Toronto from 2016 to 2021.

In addition to their academic degrees, Miranda Carleton has obtained several certifications. In March 2021, they received a certification in Drug Commercialization from UC San Diego. In February 2021, they obtained certifications in Clinical Development 201: Phase I and Clinical Development 301: Phase II/III from Biotech Primer. Prior to these, in January 2021, they completed a certification in Clinical Development 101: General Principles from the same institution. In December 2020, they earned certifications in Drug Discovery of Biologics, Drug Discovery of Small Molecules, and Preclinical Development, all from Biotech Primer. Furthermore, Miranda Carleton has obtained two certifications from LinkedIn, one in Developing Your Emotional Intelligence and another in Leading and Working in Teams, both obtained in April 2020. No other assumptions can be made about their education history or additional certifications.